Tag: Notable

James Altucher walks through what Starlink's expanding constellation signals about the company's future and why most investors haven't connected the dots.

The global laboratory equipment services market is set to soar, reaching USD 35.4 billion by 2030, expanding from USD 18 billion in 2025, with a CAGR of 14.5%. This growth is spurred by increased R&D investments, higher healthcare spending, and technological advancements. The Asia-Pacific region leads with the highest CAGR, fueled by robust infrastructure growth in countries like China and India. Dominating segments include analytical equipment and the comprehensive Gold Support Plan. Key drivers include automation, regulatory needs, and expanding lab services, with notable market players like Agilent Technologies and Thermo Fisher Scientific shaping the landscape.

153-unit Class-A apartment community with commercial space set to break ground Fall 2026 in partnership with the City of Evansville, IEDC, and Southwest Indiana RDA

ROCKVILLE, Md. and SUZHOU, China, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced that it has received clearance by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to conduct GLORA-4 study (NCT06641414), a global registrational Phase III study of lisaftoclax (APG-2575), a proprietary Bcl-2 inhibitor, in combination with azacitidine (AZA), for the treatment of patients with newly diagnosed higher-risk myelodysplastic syndrome (HR-MDS).